Job title: Executive Director & Head, Precision Medicine
Jennifer is currently Executive Director and Head of Precision Medicine, Early Clinical Development & Experimental Sciences at Regeneron, leading a team currently of 33 employees and growing. Jennifer has 21 years of pharmaceutical industry research experience, 18 of which have been with Regeneron. The Precision Medicine team leads the strategic application of biomarkers for clinical development, including target engagement and disease biomarkers, translational research, life cycle management, pharmacogenetics and predictive medicine, including companion diagnostics, across the Regeneron clinical development portfolio. Prior to taking on the departmental leadership role in 2017, Jennifer led Precision Medicine Strategies for a number of development programs, including dupilumab. Prior to joining Regeneron, Jennifer earned an Honor’s Bachelor’s of Science degree from Purdue University; a Ph.D. in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota; and completed a postdoctoral fellowship at Eli Lilly and Co.
2.40 | 11.40 Live Audience Q+A 2:40 pm
day: Day One
2.20 | 11.20 Science to Medicine: Using Biomarkers & Genetics for Indication Selection & Prioritization in Drug Development 2:20 pm
day: Day One